We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
(+31%)
Cap. Flow
+$324M
Cap. Flow
% of AUM
2.32%
Top 10 Holdings %
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$176M |
| 2 |
Infosys
INFY
|
+$102M |
| 3 |
K
Kellanova
K
|
+$74.6M |
| 4 |
Amazon
AMZN
|
+$58.6M |
| 5 |
Alibaba
BABA
|
+$52.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$114M |
| 2 |
HDFC Bank
HDB
|
+$97.7M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$55.3M |
| 4 |
Roper Technologies
ROP
|
+$45.7M |
| 5 |
Nutanix
NTNX
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.38% |
| 2 | Financials | 4.13% |
| 3 | Consumer Discretionary | 2.33% |
| 4 | Communication Services | 2.26% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
PUT
RTX Corp
RTX
$294B
| $1.8M | 0.01% |
12,300
-9,500
| -44% | -$1.27M |
|
627
PUT
AstraZeneca
AZN
$263B
| $1.8M | 0.01% |
12,850
-12,250
| -49% | -$1.72M |
|
|
OPTU
628
CALL
Optimum Communications Inc
OPTU
$298M
| $1.76M | 0.01% |
+820,700
| New | +$1.92M |
|
629
CALL
Twilio
TWLO
$29.5B
| $1.74M | 0.01% |
14,000
| – | – |
|
630
CALL
Booking.com
BKNG
$145B
| $1.74M | 0.01% |
7,500
-7,500
| -50% | -$1.54M |
|
631
PUT
Johnson Controls International
JCI
$87.5B
| $1.73M | 0.01% |
16,400
-100
| -0.6% | -$9.21K |
|
632
Duolingo
DUOL
$6.19B
| $1.73M | 0.01% |
+4,217
| New | +$1.85M |
|
633
ReNew
RNW
$2.2B
| $1.73M | 0.01% |
250,000
| – | – |
|
634
PUT
Shopify
SHOP
$165B
| $1.72M | 0.01% |
14,900
-20,700
| -58% | -$2.07M |
|
635
PUT
Meta Platforms (Facebook)
META
$1.51T
| $1.7M | 0.01% |
+2,300
| New | +$1.42M |
|
636
Intel
INTC
$462B
| $1.69M | 0.01% |
75,600
-2,102,146
| -97% | -$43.6M |
|
637
CALL
Baidu
BIDU
$35.8B
| $1.67M | 0.01% |
19,500
-21,900
| -53% | -$1.89M |
|
|
638
PUT
Baidu
BIDU
$35.8B
| $1.67M | 0.01% |
19,500
+9,500
| +95% | +$820K |
|
639
BioNTech
BNTX
$23B
| $1.65M | 0.01% |
15,500
+12,726
| +459% | +$1.29M |
|
640
Surgery Partners
SGRY
$1.98B
| $1.65M | 0.01% |
74,053
+11,755
| +19% | +$261K |
|
|
641
CALL
Amazon
AMZN
$2.49T
| $1.65M | 0.01% |
+7,500
| New | +$1.48M |
|
642
PUT
Canadian Natural Resources
CNQ
$93.4B
| $1.65M | 0.01% |
+52,400
| New | +$1.59M |
|
|
MNTN
643
MNTN Inc
MNTN
$689M
| $1.64M | 0.01% |
+75,088
| New | +$1.73M |
|
|
ALE
644
DELISTED
Allete
ALE
| $1.63M | 0.01% |
+25,471
| New | +$1.66M |
|
645
Sociedad Química y Minera de Chile
SQM
$19.6B
| $1.62M | 0.01% |
+46,000
| New | +$1.57M |
|
646
CALL
Altria Group
MO
$122B
| $1.62M | 0.01% |
27,600
+14,900
| +117% | +$875K |
|
647
CALL
ZIM Integrated Shipping Services
ZIM
$2.96B
| $1.61M | 0.01% |
100,000
+75,800
| +313% | +$1.19M |
|
|
648
PUT
ZIM Integrated Shipping Services
ZIM
$2.96B
| $1.61M | 0.01% |
100,000
+75,800
| +313% | +$1.19M |
|
|
649
AstraZeneca
AZN
$263B
| $1.6M | 0.01% |
11,448
+11,273
| +6,442% | +$1.58M |
|
650
PUT
CME Group
CME
$92.3B
| $1.6M | 0.01% |
+5,800
| New | +$1.58M |
|
Similar funds
AS
TI
LMR Partners's Q2 2025 Portfolio in Review
As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
- LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
- LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
- LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
- LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
- LMR Partners opened 418 new positions and closed 391 in Q2 2025.
- LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.
Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.